Tag: Cost Increases

In this action, the Plaintiffs, the Attorneys General of most of the States and several U.S. territories (“the States”), alleged that twenty-six pharmaceutical companies (“the Defendants”) participated in an overarching conspiracy to fix prices, allocate markets, and rig bids in the sale of generic drugs for skin ailments, and are thus jointly and severally liable…